Brilique 90 mg film-coated tablets

Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Ticagrelor
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/10/655/001-6

90 milligram(s)

B01AC24

Film-coated tablet

Product Notice

Brilique 90mg Film-Coated Tablets (100 Pack) will be discontinued as of 17th July 2026. Please note the 56 pack size will remain on the market.

Address:
College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925
Medical Information E-mail:
mipqc.ireland@astrazeneca.com
Telephone:
+353 1 609 7100
Fax:
+353 1 686 5038
Website:
https://contactazmedical.astrazeneca.com
Medical Information Direct Line:
1800800899